Crossmark

Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan

Crossref DOI link: https://doi.org/10.1186/s12885-015-1675-1

Published Online: 2015-10-09

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Eto, Masatoshi

Kawano, Yoshiaki

Hirao, Yoshihiko

Mita, Koji

Arai, Yoichi

Tsukamoto, Taiji

Hashine, Katsuyoshi

Matsubara, Akio

Fujioka, Tomoaki

Kimura, Go

Shinohara, Nobuo

Tatsugami, Katsunori

Hinotsu, Shiro

Naito, Seiji
License Information

License valid from 2015-10-09